BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24651674)

  • 21. Elevated oxidative DNA damage in patients with coronary artery disease and its association with oxidative stress biomarkers.
    Bhat MA; Gandhi G
    Acta Cardiol; 2019 Apr; 74(2):153-160. PubMed ID: 29914299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA mismatch repair network gene polymorphism as a susceptibility factor for pancreatic cancer.
    Dong X; Li Y; Chang P; Hess KR; Abbruzzese JL; Li D
    Mol Carcinog; 2012 Jun; 51(6):491-9. PubMed ID: 21681824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Polymorphisms in the oxidative stress-related genes and cancer risk].
    Janicka A; Szymańska-Pasternak J; Bober J
    Ann Acad Med Stetin; 2013; 59(2):18-28. PubMed ID: 25026746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between single nucleotide polymorphisms of X-ray repair cross-complementing protein 4 gene and development of pancreatic cancer.
    Ding Y; Li LN
    Genet Mol Res; 2015 Aug; 14(3):9626-32. PubMed ID: 26345895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. His595Tyr polymorphism in the methionine synthase reductase (MTRR) gene is associated with pancreatic cancer risk.
    Ohnami S; Sato Y; Yoshimura K; Ohnami S; Sakamoto H; Aoki K; Ueno H; Ikeda M; Morizane C; Shimada K; Sakamoto Y; Esaki M; Saito I; Hirose H; Saito D; Sugimura H; Kosuge T; Okusaka T; Yoshida T
    Gastroenterology; 2008 Aug; 135(2):477-88. PubMed ID: 18515090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myeloperoxidase and superoxide dismutase polymorphisms are associated with an increased risk of developing pancreatic adenocarcinoma.
    Wheatley-Price P; Asomaning K; Reid A; Zhai R; Su L; Zhou W; Zhu A; Ryan DP; Christiani DC; Liu G
    Cancer; 2008 Mar; 112(5):1037-42. PubMed ID: 18205184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between DNA damage, DNA repair genes variability and clinical characteristics in breast cancer patients.
    Synowiec E; Stefanska J; Morawiec Z; Blasiak J; Wozniak K
    Mutat Res; 2008 Dec; 648(1-2):65-72. PubMed ID: 18977234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A replication study and genome-wide scan of single-nucleotide polymorphisms associated with pancreatic cancer risk and overall survival.
    Willis JA; Olson SH; Orlow I; Mukherjee S; McWilliams RR; Kurtz RC; Klein RJ
    Clin Cancer Res; 2012 Jul; 18(14):3942-51. PubMed ID: 22665904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic polymorphisms in DNA repair and oxidative stress pathways associated with malignant melanoma susceptibility.
    Ibarrola-Villava M; Peña-Chilet M; Fernandez LP; Aviles JA; Mayor M; Martin-Gonzalez M; Gomez-Fernandez C; Casado B; Lazaro P; Lluch A; Benitez J; Lozoya R; Boldo E; Pizarro A; Martinez-Cadenas C; Ribas G
    Eur J Cancer; 2011 Nov; 47(17):2618-25. PubMed ID: 21641795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Single Nucleotide Polymorphisms of Base Excision Repair Genes on DNA Damage and Efficiency of DNA Repair in Recurrent Depression Disorder.
    Czarny P; Kwiatkowski D; Toma M; Kubiak J; Sliwinska A; Talarowska M; Szemraj J; Maes M; Galecki P; Sliwinski T
    Mol Neurobiol; 2017 Aug; 54(6):4150-4159. PubMed ID: 27324896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Common Susceptibility Variants of Pancreatic Cancer in Higher-Risk Patients: A PACGENE Study.
    Childs EJ; Chaffee KG; Gallinger S; Syngal S; Schwartz AG; Cote ML; Bondy ML; Hruban RH; Chanock SJ; Hoover RN; Fuchs CS; Rider DN; Amundadottir LT; Stolzenberg-Solomon R; Wolpin BM; Risch HA; Goggins MG; Petersen GM; Klein AP
    Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1185-91. PubMed ID: 27197284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An association selected polymorphisms of XRCC1, OGG1 and MUTYH gene and the level of efficiency oxidative DNA damage repair with a risk of colorectal cancer.
    Przybylowska K; Kabzinski J; Sygut A; Dziki L; Dziki A; Majsterek I
    Mutat Res; 2013; 745-746():6-15. PubMed ID: 23618615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential functional variants in SMC2 and TP53 in the AURORA pathway genes and risk of pancreatic cancer.
    Feng Y; Liu H; Duan B; Liu Z; Abbruzzese J; Walsh KM; Zhang X; Wei Q
    Carcinogenesis; 2019 Jun; 40(4):521-528. PubMed ID: 30794721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive SNP scan of DNA repair and DNA damage response genes reveal multiple susceptibility loci conferring risk to tobacco associated leukoplakia and oral cancer.
    Mondal P; Datta S; Maiti GP; Baral A; Jha GN; Panda CK; Chowdhury S; Ghosh S; Roy B; Roychoudhury S
    PLoS One; 2013; 8(2):e56952. PubMed ID: 23437280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pancreatic Cancer Risk Associated with Prediagnostic Plasma Levels of Leptin and Leptin Receptor Genetic Polymorphisms.
    Babic A; Bao Y; Qian ZR; Yuan C; Giovannucci EL; Aschard H; Kraft P; Amundadottir LT; Stolzenberg-Solomon R; Morales-Oyarvide V; Ng K; Stampfer MJ; Ogino S; Buring JE; Sesso HD; Gaziano JM; Rifai N; Pollak MN; Anderson ML; Cochrane BB; Luo J; Manson JE; Fuchs CS; Wolpin BM
    Cancer Res; 2016 Dec; 76(24):7160-7167. PubMed ID: 27780823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic variants involved in oxidative stress, base excision repair, DNA methylation, and folate metabolism pathways influence myeloid neoplasias susceptibility and prognosis.
    Gonçalves AC; Alves R; Baldeiras I; Cortesão E; Carda JP; Branco CC; Oliveiros B; Loureiro L; Pereira A; Nascimento Costa JM; Sarmento-Ribeiro AB; Mota-Vieira L
    Mol Carcinog; 2017 Jan; 56(1):130-148. PubMed ID: 26950655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cystic fibrosis transmembrane regulator (CFTR) DeltaF508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreatic cancer. PANKRAS II Study Group.
    Malats N; Casals T; Porta M; Guarner L; Estivill X; Real FX
    Gut; 2001 Jan; 48(1):70-4. PubMed ID: 11115825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of mitotic regulation pathway polymorphisms with pancreatic cancer risk and outcome.
    Couch FJ; Wang X; Bamlet WR; de Andrade M; Petersen GM; McWilliams RR
    Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):251-7. PubMed ID: 20056645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of genetic variants of ABCB1, APOB, CAV1, and NAMPT on susceptibility to pancreatic ductal adenocarcinoma in Chinese patients.
    Li B; Zhang C; Wang J; Zhang M; Liu C; Chen Z
    Mol Genet Genomic Med; 2020 Jun; 8(6):e1226. PubMed ID: 32243098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA adducts, genetic polymorphisms, and K-ras mutation in human pancreatic cancer.
    Li D; Firozi PF; Zhang W; Shen J; DiGiovanni J; Lau S; Evans D; Friess H; Hassan M; Abbruzzese JL
    Mutat Res; 2002 Jan; 513(1-2):37-48. PubMed ID: 11719088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.